Skip to main content
. Author manuscript; available in PMC: 2018 Apr 29.
Published in final edited form as: Pharmacogenomics J. 2017 May 23;18(2):295–300. doi: 10.1038/tpj.2017.18

Table 2.

Summary of EXE, 17β-DHE and 17β-DHE-Gluc concentrations in 96 plasma and 92 urine specimens from EXE-treated subjects.

plasma (nM) urine (nM) urine, creatinine-adjusted (nmol/mg creatinine)
mean (95% CI) range mean (95% CI) range mean (95% CI) range
EXE 23 (17–29) 0–157 161 (101–221) 0.24–1709 0.41 (0.24–0.57) 0.001–4.0
17β-DHE 6.0 (5.1–6.9) 0.03–30 9.1 (6.1–12) 0–86 0.022 (0.014–0.029) 0–0.21
17β-DHE-Gluc 46 (31–60) 0–461 1048 (525–1572) 0.48–22562 1.8 (1.0–2.7) 0.001–34